ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 352299 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 352299; 2) Community: the network communities that were significantly associated with the response to NSC 352299; 3) Molecule: the relationships between components within communities and NSC 352299; 4) MDR: the compounds that were significantly associated with the NSC 352299.

NSC Compound Enrichment Correlation
NSC 715648 Null 0.00648124190744032 0.26809336
NSC 746149 N,N'-bis(4-bromo-2-fluorobenzoyl)-L-selenocystine bis(4-methoxyphenacyl) ester hemihydrate 0.00648124190744032 0.37960305
NSC 669382 Null 0.00671035899671664 0.070629575
NSC 92954 Card-20(22)-enolide, 3-(acetyloxy)-5,14-dihydroxy-19-oxo-, (3.beta.,5.beta.)- (9CI) 0.00671035899671664 -0.085524319
NSC 681638 Camptothecin Derivative 0.00705866970012644 0.34478763
NSC 730870 Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-ethylamino-ethyl}amine Tris(trifluoroacetate) 0.00705866970012644 0.10265989
NSC 740203 Null 0.00705866970012644 -0.040573125
NSC 287459 Cytarabine AY 0.00705866970012649 0.069801852
NSC 339638 2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt 0.0070787592519192 -0.44030722
NSC 671898 Null 0.00707875925191925 0.16500886
Total:53  Current:8    [First] [Prev] [Next] [Last]